Jason McCarthy

Maxim Group

Image: Jason McCarthy

Jason McCarthy, Ph.D., is an equity research analyst covering the biotechnology industry at Maxim Group. McCarthy joined Maxim Group in July 2014. Prior to joining Maxim he received his doctoral degree in biomedical sciences from the Albert Einstein College of Medicine. McCarthy also holds master's degrees in both biomedical research (Albert Einstein College of Medicine) and molecular biology (Adelphi University), as well as a bachelor's degree in biochemistry from Stony Brook University. He closely follows gene therapy, CAR-T and the cancer immunology spaces, as well as many traditional biotechnology companies.

Recent Quotes

"We initiate coverage on AWKNF with a Buy rating."

— Jason McCarthy, Maxim Group (9/1/21)
more >

Due to permission requirements, not all quotes are shown.